Accelerator Corp.
4
3M
4
0.22
2
- Stages of investment
- Areas of investment
Summary
Accelerator Corp. appeared to be the VC, which was created in 2003. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Seattle.
The common things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2016. This Accelerator Corp. works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2013. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations.
Besides them, we counted 7 critical employees of this fund in our database.
The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Oncofactor Corporation, Rodeo Therapeutics, ApoGen Biotechnologies. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Accelerator Corp., startups are often financed by OVP Venture Partners, DFJ, Clarus Ventures. The meaningful sponsors for the fund in investment in the same round are Washington Research Foundation., ARCH Venture Partners, WuXi AppTec. In the next rounds fund is usually obtained by M Ventures, CRG L.P..
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.22
- Investments by industry
- Biotechnology (4)
- Health Care (2)
- Pharmaceutical (2)
- Therapeutics (2)
- Medical (1) Show 1 more
- Investments by region
-
- United States (4)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 13M
- Group Appearance index
- 1.00
- Avg. company exit year
- 4
- Avg. multiplicator
- 3.69
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Rodeo Therapeutics | 25 Jul 2017 | Biotechnology, Pharmaceutical, Therapeutics | Early Stage Venture | 5M | United States, Washington, Seattle |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.